Participated · Series C · Aug 2026

Lovable is a vibe-coding startup that hosts 60 million projects and attracts 900 million monthly visitors. The company reported a $500 million annualized run rate in June. It offers its own in-house trained AI model in addition to frontier model options and has increased backend capacity and technical sophistication as it has scaled. Lovable signed a multiyear deal with Google Cloud, which the company says led to a fivefold increase in usage. The startup has also invested in other European startups such as Danish company Atech. Recent funding rounds have significantly increased its valuation and capital base.

Participated · Series C · Oct 2025

Dexory provides a data intelligence platform, DexoryView, that combines autonomous robots, AI and digital twin technology to deliver full operational visibility and real-time insights for warehouse and supply chain operators. The platform is positioned to provide visibility from day one and to accelerate value capture compared with conventional solutions. The company is led by CEO Andrei Danescu and is headquartered in London. Following the additional Series C tranche, Dexory intends to accelerate its product roadmap and expand access to its technology into multiple international markets and new sectors. Dexory has attracted a mix of new and existing investors including Eurazeo, Atomico and others. Specific financial metrics such as revenue or user counts were not disclosed in the announcement.

Participated · Series C · Oct 2021

Twin Health combines advanced medical science and technology with a clinical care team to help people take control of conditions like type 2 diabetes, prediabetes, and obesity. Its metabolic health benefit is offered exclusively through employers or health plans. The company’s Digital Twin technology learns a member’s unique metabolism from smart devices, meal logs, and lab work to provide real-time, personalized recommendations on nutrition, activity, sleep, stress, and more. A clinical care team then guides the member on a clear path toward their health goals. Twin Health plans to use new funding to expand operations, advance product development, and broaden its business reach. The company is based in Mountain View, California. Twin Health builds the Whole Body Digital Twin™, a dynamic, AI-powered model of each individual’s metabolism designed to reverse, improve, and prevent chronic metabolic diseases. Led by CEO and founder Jahangir Mohammed, the model is constructed from thousands of daily data points drawn from wearable sensors, clinical lab parameters, and self-reported preferences. Through a mobile app, it delivers individualized, timely guidance to members and Twin Health’s licensed clinical care teams across nutrition, sleep, activity, and stress. The company’s chronic metabolic disease solution is available today through employer and health plan partners. Twin Health raised $50M and intends to use the proceeds to continue expanding its technology and clinical service solutions for more members across the United States. The offering emphasizes personalized, data-driven interventions to manage metabolic health. Twin Health built the Whole Body Digital Twin™, an AI-powered, individualized metabolic model that ingests thousands of daily data points from non-invasive wearable sensors and self-reported preferences to provide personalized nutrition, sleep, activity and breathing guidance. The service combines continuous glucose monitors, fitness watches, comprehensive blood tests, an app, consultations with healthcare providers and Twin coaches, and is delivered through partner programs such as employer benefits and health insurance plans. Twin's clinical research includes the world’s first randomized controlled trial using digital twin technology, with published early RCT data showing a mean HbA1c reduction of 3.1 (baseline 8.7), over 90% achieving type 2 diabetes reversal (HbA1c <6.5), and 92% eliminating diabetes medications including insulin. Patients in the trial also averaged a 9.1 kg (20 lb) weight reduction and, among those with elevated ALT, an average ALT reduction of 24 units/L; control participants did not achieve reversal or comparable improvements. Founded in 2018 by Jahangir Mohammed, the company says its technology continuously monitors individuals' metabolism to enable timely, data-driven interventions addressing root causes of chronic metabolic disease. Twin Health announced a $140 million Series C to scale the Whole Body Digital Twin™ service in the U.S. and globally.

Participated · Series E · Jan 2021

K Health offers a clinical‑grade AI ‘co‑pilot’ for primary care that conducts personalized patient chats, grounds assessments in EMRs, and generates provider-ready medical charts to streamline diagnosis and treatment. The platform integrates virtual care with health‑system brick‑and‑mortar assets to provide longitudinal care and navigation to diagnostics and specialty services. K says the model has helped partners increase primary care access by 15% and is available to millions of people in the U.S. through health systems, insurers, and a direct‑to‑consumer mobile app. The company operates a 24/7 virtual primary care service that assigns providers and emphasizes higher‑quality, lower‑cost care compared with traditional models. K Health has been developing its AI technology for over seven years and employs proprietary datasets to personalize care. The company recently raised equity capital, underscoring continued investor support as it scales. K Health is a digital primary care platform that consolidates the knowledge of thousands of doctors and billions of clinical data insights to offer symptom guidance, treatment options, and remote visits. The company offers free AI-powered symptom checking built from millions of users and thousands of pediatricians, plus paid chat visits with doctors for less than a copay. It recently launched K for Parents, a virtual pediatrics product for ages 3–17 that combines a free symptom checker with pediatric televisits (adult membership $9/month for unlimited care; one-time visits $19). K Health says K Primary Care is available in 49 states and the app is available in all 50 states, covering 300 million people; the app is frequently the #1 downloaded in the App Store medical category. The company has partnerships and collaborations including the Mayo Clinic Platform, Maccabi Healthcare Services, and an offering to Anthem’s 43 million members. K Health closed a $132M Series E to support continued expansion of its product and care offerings. K Health offers an AI-powered telemedicine app that ingests medical histories, clinical outcomes and the experience of more than 10,000 doctors to provide symptom triage and treatment information. Its backend compares user profiles to a corpus of over 400 million clinical notes and a 20-year database of millions of electronic health records sourced from Maccabi and health systems in the U.S. and Mexico. The app facilitates in‑app visits, prescription delivery, and mental-health services with tiered pricing (e.g., $9/month, $19 one-time, $29 three-month unlimited; $34/month for medication delivery). K Health says it has more than 4 million members, is adding 10,000–15,000 users per day, has grown 1,000% this year, and saw over one million new users since the pandemic began. The company has partnerships with insurers like Anthem (including a cobranded CareSpree product) and institutions such as Louisiana State University. It announced a collaboration with the Mayo Clinic to integrate the Clinic Data Analytics Platform and plans to use recent funding to grow its telemedicine offering. K Health provides an app that asks users about symptoms and, accounting for age, gender and medical history, shows how similar patients were diagnosed and treated. The platform ingests medical histories, clinical outcomes and the collective experience of more than 10,000 doctors to deliver treatment information across hundreds of diseases. Users can chat with a doctor on call for diagnosis, advice, prescriptions and lab test orders. K Health uses anonymized data to improve its service and states it will never sell, rent or share personal health information; it also complies with HIPAA and GDPR. Led by co-founder Allon Bloch, the company operates its service from New York City and Tel Aviv. The company plans to grow its telemedicine offering and translate the platform into Spanish. K Health provides an AI-driven triage and symptom-checker platform that uses licensed data and a chatbot interview to derive likely conditions and recommend routes to care. The company’s app also lets users connect with board-certified doctors via text chat, who can discuss treatment options and prescribe medications or lab tests if needed. K Health launched its U.S. consumer app last year and has grown to more than 1.3 million users, adding roughly 15,000 new users per day. The startup charges $49 annually for unlimited chat with a doctor in its standard app, while Anthem members will receive symptom-checker services for free under the co-branded agreement. K Health employs about 50 clinicians through an associated physicians group and currently offers services in 14 states between 11 a.m. and 11 p.m. The company plans to expand into pediatrics by the end of the year and eventually into areas like orthopedics and chronic disease management, and expects to pursue similar insurer partnerships and broader distribution, including to non-members.